Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Completed · Phase 1

Conditions studied: Acne

In brief

Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.

Key facts

Study ID

NCT02850003

Run by

Bausch Health Americas, Inc.

People needed

20

Starts

2016-06-01

Expected to finish

2016-11-01

Last updated by the study team

2017-09-25

Who can join

Age: 9 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 01 — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.